Drug development is an arduous and expensive exercise. We seek to produce innovative compounds efficiently and effectively.

SEC Filings

Filing	Description	Date Filed	Size
4	sachdev, amit	Feb 8, 2010	21.0 KB
4	silva, paul m	Feb 8, 2010	21.0 KB
4	emmens, matthew	Feb 8, 2010	20.7 KB
4	boger, kenneth s	Feb 8, 2010	20.9 KB
4	mueller, peter	Feb 8, 2010	21.0 KB
4	smith, ian f	Feb 8, 2010	21.0 KB
4	kelly, lisa	Feb 8, 2010	21.0 KB
8-K	current report	Feb 4, 2010	116.5 KB
4	mueller, peter	Feb 4, 2010	20.6 KB
CT ORDER	confidential treatment order	Feb 2, 2010	12.9 KB
CT ORDER	confidential treatment order	Feb 2, 2010	13.1 KB
SC 13G	statement of beneficial ownership	Jan 29, 2010	25.5 KB
4	kelly, lisa	Jan 27, 2010	20.6 KB
4	mueller, peter	Jan 27, 2010	20.6 KB
4	mueller, peter	Jan 19, 2010	21.9 KB
8-K	current report	Jan 11, 2010	75.9 KB
4	wysenski, nancy	Dec 11, 2009	21.6 KB
3	wysenski nancy	Dec 11, 2009	16.5 KB
4	mueller, peter	Dec 9, 2009	21.5 KB
8-K	current report	Dec 4, 2009	303.8 KB
Showing 1-20 of 1066 Page: 1 2 3 ... 54  Next 20